Overview Treatment of Acute Pancreatitis With Ketorolac Status: Terminated Trial end date: 2019-02-01 Target enrollment: Participant gender: Summary Patients with acute pancreatitis will be randomly assigned in either study group to receive oral (injection) Ketorolac or the control group. In patients who cannot tolerate oral medications, ketorolac injection will be used. Phase: Phase 4 Details Lead Sponsor: Ilam University of Medical SciencesTreatments: KetorolacKetorolac Tromethamine